Cue Biopharma Stock Quote CUE - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.5537

Bid

0.55

Ask

0.565

Volume

125,149

0.5495 Day's Range 0.575

0.5395 52 Week Range 3.2491

Market Cap

26.934M

Previous Close

0.57

Open

0.56

Last Trade

0.565

Last Trade Time

Financial Volume

$ 69,876

VWAP

0.558345

Average Volume (3m)

391,864

Shares Outstanding

48,643,316

Dividend Yield

PE Ratio

-0.54

Earnings Per Share (EPS)

-1.04

Revenue

5.49M

Net Profit

-50.73M

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cuebiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CUE. The last closing price for Cue Biopharma was $0.57. Over the last year, Cue Biopharma shares have traded in a share price range of $ 0.5395 to $ 3.2491.

Cue Biopharma currently has 48,643,316 shares outstanding. The market capitalization of Cue Biopharma is $27.73 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -0.54.

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0063	-1.125	0.56	0.63	0.5413	154653	0.57897214	CS
4	-0.3463	-38.4777777778	0.9	1	0.5395	199318	0.68334861	CS
12	-0.9163	-62.3333333333	1.47	1.58	0.5395	391864	0.81305349	CS
26	-1.5163	-73.2512077295	2.07	2.26	0.5395	330118	1.23068998	CS
52	-2.0063	-78.37109375	2.56	3.2491	0.5395	321485	1.81862364	CS
156	-12.1263	-95.6332807571	12.68	18.42	0.5395	318518	4.37387915	CS
260	-8.7363	-94.0398277718	9.29	35.5	0.5395	306228	8.77385969	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OMEXOdyssey Marine Exploration Inc	$ 1.39 (180.07%)	328.97M
PRTGPortage Biotech Inc	$ 9.7581 (115.41%)	51.55M
APLTApplied Therapeutics Inc	$ 7.86 (69.03%)	51.67M
XCHXCHG Ltd	$ 18.40 (65.77%)	1.26M
WBUYWeBuy Global Ltd	$ 0.1867 (60.95%)	248.03M
GLMDGalmed Pharmaceuticals Ltd	$ 6.83 (-54.77%)	6.24M
KAKineta Inc	$ 0.5691 (-31.35%)	530.74k
DTSSDatasea Inc	$ 2.07 (-29.59%)	1.34M
CBUSCibus Inc	$ 3.595 (-28.95%)	2.31M
BFIBurgerFi International Inc	$ 0.1705 (-26.98%)	16.56M
OMEXOdyssey Marine Exploration Inc	$ 1.39 (180.07%)	328.97M
NVDANVIDIA Corporation	$ 113.37 (-1.92%)	310.35M
WBUYWeBuy Global Ltd	$ 0.1867 (60.95%)	248.03M
SQQQProShares UltraPro Short QQQ	$ 8.40 (1.45%)	200.73M
LUNRIntuitive Machines Inc	$ 7.4512 (37.99%)	141.86M